Chen L, Peng YT, Chen FL, Tung TH. Epidemiology, management, and economic evaluation of screening of gallstone disease among type 2 diabetics: A systematic review. World J Clin Cases 2015; 3(7): 599-606 [PMID: 26244151 DOI: 10.12998/wjcc.v3.i7.599]
Corresponding Author of This Article
Dr. Tao-Hsin Tung, Department of Medical Research and Education, Cheng-Hsin General Hospital, Shih-Pai, Taipei 112, Taiwan. ch2876@chgh.org.tw
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Lujie Chen, Yu-Ting Peng, Fu-Li Chen, Tao-Hsin Tung, Faculty of Public Health, College of Medicine, Fu-Jen Catholic University, Taipei 24205, Taiwan
Tao-Hsin Tung, Department of Medical Research and Education, Cheng-Hsin General Hospital, Taipei 112, Taiwan
Author contributions: Chen L and Tung TH drafted the manuscript; Peng YT and Chen FL coordinated drafting the manuscript; all authors read and approved the final version of the manuscript.
Conflict-of-interest statement: We certify that all affiliations with or financial involvement in, within the past 5 years and foreseeable future, any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript are completely disclosed (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, royalties).
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Tao-Hsin Tung, Department of Medical Research and Education, Cheng-Hsin General Hospital, Shih-Pai, Taipei 112, Taiwan. ch2876@chgh.org.tw
Received: October 27, 2014 Peer-review started: October 29, 2014 First decision: December 12, 2014 Revised: March 10, 2015 Accepted: April 10, 2015 Article in press: April 14, 2015 Published online: July 16, 2015
Abstract
The knowledge of gallstone disease (GSD) is crucial to manage this condition when organizing screening and preventive strategies and identifying the appropriated clinical therapies. Although cholecystectomy still be the gold standard treatment for patients with symptomatic GSD, expectant management could be viewed as a valid therapeutic method for this disorder. If early treatment of GSD decreases the morbidity or avoids further cholecystectomy, it may save clinical care costs in later disease periods sufficiently to offset the screening and early treatment costs. In addition, whether routine screening for GSD is worthwhile depends on whether patients are willing to pay the ultrasonography screening cost that would reduce the risk of cholecystectomy. In this review we discuss the epidemiology, management, and economic evaluation of screening of GSD among type 2 diabetics.
Core tip: According to the willingness-to-pay viewpoint, this review indicated that from the societal perspective but not from consumer viewpoint, it is worthwhile to organize a routine ultrasonography screening for gallstone disease in diabetic population for further cholecystectomy prevention.
